Triochem Products
In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was ₹0.09 Cr, against −₹0.03 Cr a year earlier (compared with Jun 2025). Promoters held 68.65% of Triochem Products in Sep 2026, unchanged from Jun 2026.
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcareLast traded 22 May 2020 · EPS basis: Standalone · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,765.10 | 35.01 | 4,23,507 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,651.00 | 87.59 | 2,56,204 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,595.60 | 72.14 | 1,74,802 Cr | 9.51 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,190.00 | 108.20 | 1,18,328 Cr | 22.33 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.40 | 26.29 | 1,17,845 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,337.70 | 34.65 | 1,11,655 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,362.00 | 32.63 | 1,10,030 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Triochem Products (this company) | ₹17.40 | 0.05 | 0 Cr | 0.04 | 0.00% | 38.60% | 50.83% | 12 Cr | 8 Cr |
| Median 8 companies | ₹1,563.55 | 34.83 | 1,18,087 Cr | 4.71 | 0.47% | 14.56% | 18.45% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -15.6% over last 3 years.
Technical Indicators
Oscillators
Bearish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.26 | 0.29 | 0.24 | 0.33 | 0.31 | 0.3 | 0.59 | 0.33 | 0.36 | 0.43 | 0.38 | 0.22 | 0.05 |
| Operating Profit | -0.26 | -0.29 | -0.24 | -0.33 | -0.31 | -0.3 | -0.59 | -0.33 | -0.36 | -0.43 | -0.38 | -0.22 | -0.05 |
| Other Income | 0.14 | -1.11 | 0.04 | 0.8 | 0.23 | 0.27 | 0.46 | 0.32 | 0.22 | 0.3 | 0.22 | 11.29 | 0.17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0 |
| PBT | -0.14 | -1.42 | -0.22 | 0.45 | -0.1 | -0.05 | -0.17 | -0.03 | -0.16 | -0.15 | -0.17 | 10.99 | 0.12 |
| Tax % | -21.43% | -27.46% | -4.55% | 28.89% | -20% | -20% | -147.06% | 1400% | -75% | 33.33% | -23.53% | 24.2% | 25% |
| Net Profit | -0.11 | -1.03 | -0.2 | 0.32 | -0.08 | -0.04 | 0.09 | -0.45 | -0.03 | -0.19 | -0.13 | 8.33 | 0.09 |
| EPS (₹) | -4.49 | -42.04 | -8.16 | 13.06 | -3.27 | -1.63 | 3.67 | -18.37 | -1.22 | -7.76 | -5.31 | 340 | 3.67 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.68 | 23.11 | 18.06 | 34.99 | 12.35 | 20.03 | 13.94 | 8.82 | 0 | 0 | -0.01 | -0.03 | 0 |
| Expenses | 29.44 | 22.11 | 17.07 | 31.18 | 10.71 | 15.48 | 14.3 | 7.47 | 1.33 | 1.05 | 1.21 | 1.34 | 1.08 |
| Operating Profit | 1.24 | 1 | 0.99 | 3.81 | 1.64 | 4.55 | -0.36 | 1.35 | -1.33 | -1.05 | -1.22 | -1.37 | -1.08 |
| OPM % | 4.04% | 4.33% | 5.48% | 10.89% | 13.28% | 22.72% | -2.58% | 15.31% | — | — | — | — | — |
| Other Income | 0.08 | -0.01 | 0.16 | 0.41 | 0.06 | 0.47 | 0.13 | 0.55 | 0.27 | -0.19 | 1.05 | 12.03 | 11.98 |
| Interest | 0.45 | 0.2 | 0.07 | 0.4 | 0.46 | 0.3 | 0.21 | 0.02 | 0 | 0 | 0 | 0.1 | 0.08 |
| Depreciation | 0.32 | 0.27 | 0.28 | 0.25 | 0.21 | 0.17 | 0.14 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 | 0.03 |
| PBT | 0.55 | 0.52 | 0.8 | 3.57 | 1.03 | 4.55 | -0.58 | 1.76 | -1.17 | -1.33 | -0.25 | 10.51 | 10.79 |
| Tax % | 23.64% | 32.69% | 28.75% | 28.57% | 29.13% | 25.27% | -24.14% | 25% | -24.79% | -24.06% | 60% | 24.17% | — |
| Net Profit | 0.42 | 0.34 | 0.58 | 2.56 | 0.74 | 3.4 | -0.45 | 1.32 | -0.89 | -1.01 | -0.4 | 7.97 | 8.1 |
| EPS (₹) | 17.14 | 13.88 | 23.67 | 104 | 30.2 | 139 | -18.37 | 53.88 | -36.33 | -41.22 | -16.33 | 325 | 331 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves | 4.31 | 4.65 | 5.24 | 7.79 | 8.53 | 11.93 | 11.47 | 12.8 | 11.35 | 14.38 | 13.42 | 20.4 |
| Borrowings | 3.5 | 0 | 2.86 | 2.28 | 5.79 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.42 | 2.12 | 1.93 | 1.47 | 0.58 | 1.94 | 0.38 | 0.28 | 0.24 | 0.25 | 0.23 | 0.23 |
| Total Liabilities | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
| Fixed Assets | 1.72 | 1.85 | 1.64 | 1.42 | 1.22 | 1.06 | 0.94 | 0.87 | 0.77 | 0.68 | 0.6 | 0 |
| CWIP | 0.37 | 0.04 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.12 | 3.68 | 0 | 0 | 0 | 0 | 0 | 0 | 9.42 | 11.07 | 10.63 | 7.89 |
| Other Assets | 6.27 | 1.45 | 8.64 | 10.37 | 13.93 | 15.53 | 11.13 | 12.46 | 1.65 | 3.13 | 2.67 | 12.99 |
| Total Assets | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.34 | 6.79 | -6.48 | 1.45 | -3.75 | 3.82 | 10.25 | 3.47 | -1.03 | -3.76 | 0.2 | -2.87 |
| Investing | -0.1 | -3.7 | 3.71 | -0.01 | 0.02 | -0.03 | 0 | 0.16 | -9.82 | 3.34 | 0.17 | 13.7 |
| Financing | -1.69 | -3.68 | 2.8 | -0.92 | 3.06 | -3.49 | -2.61 | -0.02 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.56 | -0.59 | 0.03 | 0.52 | -0.67 | 0.3 | 7.64 | 3.61 | -10.85 | -0.42 | 0.37 | 10.82 |
| Free Cash Flow | 2.24 | 6.68 | -6.51 | 1.42 | -3.76 | 3.79 | 10.23 | 3.44 | -1.03 | -3.76 | 0.2 | 8.85 |
| CFO/EBITDA | 241 | 682 | -635 | 56 | -176 | 106 | -2,939 | 287 | 105 | 351 | -17 | 64 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2.02 | 0 | 49.52 | 0 | 98.42 | 226 | 36.4 | 0 | — | — | — | — |
| Inventory Days | 55.65 | 5.85 | 52.93 | 104 | 414 | 41.57 | 24.6 | 2.9 | — | — | — | — |
| Days Payable | 1.45 | 31.02 | 36.57 | 9.13 | 14.72 | 19.85 | 9.26 | 9.85 | — | — | — | — |
| Cash Conversion Cycle | 56.22 | -25.17 | 65.88 | 95.24 | 498 | 248 | 51.74 | -6.95 | — | — | — | — |
| Working Capital Days | 16.06 | -19.43 | 63.06 | 56.23 | 217 | 191 | 63.1 | 0.83 | — | — | — | — |
| ROCE % | 11.78% | 11.57% | 12.83% | 42.53% | 11.97% | 33.16% | -2.8% | 14.45% | -10.14% | -2.67% | -3.32% | -4.37% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Triochem Products insights
66 extracted metrics + investor summaries across FY10–FY27.
Documents
Frequently Asked Questions about Triochem Products
What does Triochem Products Ltd do?
Where is Triochem Products Ltd (TRIPR) listed?
Which sector does Triochem Products Ltd belong to?
What is the PE ratio of Triochem Products Ltd?
What is the Return on Equity (ROE) of Triochem Products Ltd?
Company Information
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512101.md for Triochem Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.